Your browser doesn't support javascript.
loading
The Multifaceted Immunology of Cytokine Storm Syndrome.
Lee, Pui Y; Cron, Randy Q.
Afiliação
  • Lee PY; Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA.
  • Cron RQ; Division of Pediatric Rheumatology, Children's of Alabama, Birmingham, AL.
J Immunol ; 210(8): 1015-1024, 2023 04 15.
Article em En | MEDLINE | ID: mdl-37011407
ABSTRACT
Cytokine storm syndromes (CSSs) are potentially fatal hyperinflammatory states that share the underpinnings of persistent immune cell activation and uninhibited cytokine production. CSSs can be genetically determined by inborn errors of immunity (i.e., familial hemophagocytic lymphohistiocytosis) or develop as a complication of infections, chronic inflammatory diseases (e.g., Still disease), or malignancies (e.g., T cell lymphoma). Therapeutic interventions that activate the immune system such as chimeric Ag receptor T cell therapy and immune checkpoint inhibition can also trigger CSSs in the setting of cancer treatment. In this review, the biology of different types of CSSs is explored, and the current knowledge on the involvement of immune pathways and the contribution of host genetics is discussed. The use of animal models to study CSSs is reviewed, and their relevance for human diseases is discussed. Lastly, treatment approaches for CSSs are discussed with a focus on interventions that target immune cells and cytokines.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Juvenil / Linfo-Histiocitose Hemofagocítica / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Marrocos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Juvenil / Linfo-Histiocitose Hemofagocítica / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Marrocos